| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.9365 | 45 |
| GSM780708 | Untreated after 4 days (C2_1) | 48.3869 | 43 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.0712 | 37 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.3485 | 34 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.846 | 40 |
| GSM780721 | Untreated after 4 days (C3_2) | 57.366 | 62 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.864 | 51 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.9192 | 36 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.8771 | 31 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.1469 | 10 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.3704 | 29 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 41.2648 | 10 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 47.7219 | 40 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.8805 | 36 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.6554 | 47 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.7268 | 26 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.6605 | 53 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 52.3274 | 55 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.118 | 52 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.1529 | 52 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.6156 | 8 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.4524 | 50 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 46.911 | 36 |